PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33551815-3	2020	Both nociceptive responses and referred hyperalgesia were abolished by the ablation of TRPV1-expressing neurons (and the consequent ablation of TRPA1+ nociceptors) by resiniferatoxin (RTX) treatment, and by the TRPA1 antagonist AP18.	resiniferatoxin	167-182	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	144-149	
33551815-3	2020	Both nociceptive responses and referred hyperalgesia were abolished by the ablation of TRPV1-expressing neurons (and the consequent ablation of TRPA1+ nociceptors) by resiniferatoxin (RTX) treatment, and by the TRPA1 antagonist AP18.	resiniferatoxin	184-187	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	144-149	
33551815-3	2020	Both nociceptive responses and referred hyperalgesia were abolished by the ablation of TRPV1-expressing neurons (and the consequent ablation of TRPA1+ nociceptors) by resiniferatoxin (RTX) treatment, and by the TRPA1 antagonist AP18.	resiniferatoxin	184-187	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	211-216